celecoxib has been researched along with glutamic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Meanwell, NA | 1 |
| Chang, HK; Jang, MH; Kim, CJ; Kim, EH; Kim, YJ; Shin, MC | 1 |
| Ardestani, MS; Moghaddamt, HF; Navidpour, L; Rahmim, A; Saffari, M; Shafiee, A | 1 |
| Bauer, B; Hartz, AM; Miller, DS; Pekcec, A; Potschka, H; Unkrüer, B; Zibell, G | 1 |
| Avemary, J; Fricker, G; Noachtar, S; Peraud, A; Potschka, H; Rémi, J; Salvamoser, JD | 1 |
| Huang, SK; Lin, TY; Lu, CW; Wang, CC; Wang, SJ | 1 |
| El Sayed, NS; Sayed, AS | 1 |
8 other study(ies) available for celecoxib and glutamic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synopsis of some recent tactical application of bioisosteres in drug design.
Topics: Cytochrome P-450 Enzyme System; Drug Design | 2011 |
Modulation of cyclooxygenase-2 on glycine- and glutamate-induced ion currents in rat periaqueductal gray neurons.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Glutamic Acid; Glycine; Ion Transport; Isoenzymes; Lipopolysaccharides; Male; Membrane Potentials; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2003 |
Dopaminergic but not glutamatergic neurotransmission is increased in the striatum after selective cyclooxygenase-2 inhibition in normal and hemiparkinsonian rats.
Topics: Animals; Celecoxib; Corpus Striatum; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glutamic Acid; Male; Microdialysis; Oxidopamine; Parkinsonian Disorders; Pyrazoles; Rats; Rats, Wistar; Substantia Nigra; Sulfonamides; Synaptic Transmission | 2008 |
Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition.
Topics: Animals; Arachidonic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Capillaries; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Glutamic Acid; In Vitro Techniques; Male; Nitrobenzenes; Protein Transport; Pyrazoles; Rats; Rats, Sprague-Dawley; Status Epilepticus; Sulfonamides; Up-Regulation | 2009 |
Dynamic regulation of P-glycoprotein in human brain capillaries.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Capillaries; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Glutamic Acid; Humans; Immunohistochemistry; In Vitro Techniques; Male; Mice; Pyrazoles; Sulfonamides | 2013 |
Cyclooxygenase 2 inhibitor celecoxib inhibits glutamate release by attenuating the PGE2/EP2 pathway in rat cerebral cortex endings.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Celecoxib; Cerebral Cortex; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase 2 Inhibitors; Exocytosis; Glutamic Acid; Male; Potassium; Potassium Channel Blockers; Presynaptic Terminals; Prostaglandins E; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Sodium; Sulfonamides; Synaptosomes | 2014 |
Co-administration of 3-Acetyl-11-Keto-Beta-Boswellic Acid Potentiates the Protective Effect of Celecoxib in Lipopolysaccharide-Induced Cognitive Impairment in Mice: Possible Implication of Anti-inflammatory and Antiglutamatergic Pathways.
Topics: Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Celecoxib; Cognitive Dysfunction; Cyclooxygenase 2 Inhibitors; Drug Combinations; Drug Synergism; Glutamic Acid; Lipopolysaccharides; Lipoxygenase Inhibitors; Male; Mice; Triterpenes; Tumor Necrosis Factor-alpha | 2016 |